Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2022 PharmSci 360 Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Author
Browse by Poster Author
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
W
Walsh, Dominic
NextPharma
(
M1230-04-23
)
Formulation Design, Characterisation and In Vivo Performance of Self-Emulsifying Drug Delivery Systems (SEDDS) for a BSC Class II NCE
Dominic Walsh
Favorite
Wang, Danyi
EMD Serono
(
M0930-10-59
)
Implementing of Next-Generation Sequencing-Based Approach for Pharmacogenomics Profiling and Exploring Its Potential Clinical Utilities
Danyi Wang
Favorite
Wang, Huiliang
University of Texas at Austin
(
M1330-04-23
)
Reversible, Covalent DNA Condensation Approach via Chemical Linkers for Enhanced Gene Delivery
Huiliang Wang
Favorite
Wang, Jianping
Purdue University
(
T1530-01-01
)
Phosphatidylserine Targeting for Enhancing Immunochemotherapy of Cancer
Jianping Wang
Favorite
Wang, Jiawei
University of Texas at Austin
(
T1230-04-23
)
First-in-Class 3D Printing Technology to Fabricate 6-Thioguanine-Loaded Microparticles for Potential COVID-19 Treatment
Jiawei Wang
Favorite
Wang, Kai
Frontage Laboratories, Inc.
(
T0930-09-49
)
Validation of Ultra-High Sensitive SIMOA Assays for the Quantitation of Neurofilament Light Chain (NF-L) and Glial Fibrillary Acidic Protein (GFAP)
Kai Wang
Favorite
Wang, Lushan
University of Minnesota
(
T1030-05-28
)
Sex Difference of Glucose Transport in an Alzheimer’s disease Transgenic Mouse Model
Lushan Wang
Favorite
Wang, Qi
Auburn University
(
W1030-04-23
)
ELC-Cu Nanoparticles Induce Cell Death by Mediating Mitochondria Oxidative Stress and Trigger an Innate Immune Response for Cancer Therapy
Qi Wang
Favorite
Wang, Rhea
International Flavors & Fragrances Inc.
(
M1330-12-71
)
Application of Avicel® as Cushioning Agent in MUPS Tablets
Rhea Wang
Favorite
Wang, Ruifeng
University of Connecticut
(
M1530-04-23
)
Effect of Coacervation Processing Parameters on In Vitro Drug Release from PLGA Microspheres
Ruifeng Wang
Favorite
Wang, Ruqi
Eurofins
(
M1430-09-50
)
De Novo Development and Validation of a Flow Cytometry Method for the Detection of Neutralizing Antibodies against Adeno-Associated Virus Serotype 5 (AAV5)
Ruqi Wang
Favorite
Wang, Shih-Wen
Pfizer Inc.
(
T1430-04-23
)
Building a Chemical Space Map for In Silico Prediction of Supersaturation by Mesoporous Silica
Shih-Wen Wang
Favorite
Wang, Weili
AbbVie Inc.
(
T1130-08-47
)
Building Fundamental Understanding of Drug Release Mechanisms via Release of Functional Excipients
Weili Wang
Favorite
Wang, Xuechun
St. John's University
(
M0930-07-41
)
Surface-Modified Inhalable Microparticle-Encapsulated Triterpenoid for Enhanced Efficacy in Malignant Mesothelioma
Xuechun Wang
Favorite
(
T0930-07-41
)
Development of Scalable and Inhaled Nintedanib-Loaded Polymeric Nanoparticles for Localized Therapy of Idiopathic Pulmonary Fibrosis
Xuechun Wang
Favorite
Wang, Yan
US Food and Drug Administration
(
T1130-06-34
)
Impact of Formulation Processes on Dosage Form Determination of Phytonadione Injectables
Yan Wang
Favorite
Wang, Yanlin
Otsuka Pharmaceutical Development & Commercialization, Inc.
(
M1530-11-63
)
A Population Pharmacokinetic Modeling Approach in Determining the Absolute Bioavailability of Sibeprenlimab, an IgG2 Monoclonal Antibody, from Two Single Ascending Dose Trials in Healthy Subjects
Yanlin Wang
Favorite
Wang, Yanqia (Cha)
Agilent Technologies, Inc.
(
M1330-08-48
)
Quantification and Identity Testing of Soft Gel Capsules using Transmission Raman Spectroscopy
Yanqia (Cha) Wang
Favorite
Wang, Yihan
University of Maryland Baltimore
(
W0930-07-41
)
Nanosuspension Organic Phase Instead of Solution Water Phase: A New Approach to Loading Hydrophilic Trivalent Arsenic Salt with Hydrophobic Polymer
Yihan Wang
Favorite
Wang, Zengtao
University of Minnesota
(
M1130-10-59
)
Systems Biology Modeling of the Insulin Signaling Network in the Blood-Brain Barrier Endothelium Predicts Cerebrovascular Inflammation in Alzheimer’s disease
Zengtao Wang
Favorite
(
M1530-10-58
)
Gut Microbial Metabolites Regulate Bidirectional Transport and Intracellular Accumulation of Alzheimer’s disease Amyloid Beta Peptides at the Blood-Brain Barrier Endothelium
Zengtao Wang
Favorite
Wang, Zhaoxian (George)
Bristol Myers Squibb
(
M1030-07-41
)
Biorelevant Dissolution Method Considerations for the Appropriate Evaluation of Amorphous Solid Dispersions: Are Two Stages Necessary?
Zhaoxian (George) Wang
Favorite
Wang, Zijian
University of Minnesota
(
M1230-08-47
)
Varied Bulk Powder Properties as a Result of Particle Engineering Methods for Micronized API: Implications of Crystal Surface Anisotropy for Materials within Size Specifications
Zijian Wang
Favorite
(
T1130-04-24
)
A Potential Mechanism of Tabletability Flip Phenomenon
Zijian Wang
Favorite
Warren, Mark
BioIVT
(
T1330-11-63
)
A Novel Transcellular Assay for Monocarboxylate Transporter 10 (MCT10)
Mark Warren
Favorite
Weaver, Lauren
University of Kentucky College of Pharmacy
(
T0930-10-59
)
Interventional Treatment with an mPGES-1 Inhibitor Halts Further Growth of Abdominal Aortic Aneurysms in the Ang-II Mouse Model
Lauren Weaver
Favorite
Weber, Georg
University of Cincinnati
(
W1030-10-55
)
Seeking Novel Drug Targets for Anti-Metastasis Treatment
Georg Weber
Favorite
Wei, Hao
University of the Pacific
(
T1330-10-57
)
Female Sex Hormones Alter GHB Toxicokinetics
Hao Wei
Favorite
Wei, Yanhong
REGENXBIO, Inc.
(
W1030-09-52
)
Generation of Rabbit Anti-Peptide Monoclonal Antibodies for Microdystrophin and Dystrophin Quantitation
Yanhong Wei
Favorite
Werkman, Carolin
University of Florida
(
T1130-10-59
)
Simultaneously Inactivating Three or all Four Penicillin-Binding Proteins (PBPs) among PBP1a, 1b, 2 and 3 Synergistically Kills
Acinetobacter baumannii (AB)
Carolin Werkman
Favorite
White, Sissi
Thermo Fisher Scientific
(
M0930-09-52
)
Characterization of Lipid Nanoparticle (LNP) Composition UHPLC-CAD
Sissi White
Favorite
Williams, Stuart
Aerie Pharmaceuticals
(
T1130-07-41
)
Cyclodextrin Enabled Formulations of Unstable and Poorly Soluble Compounds for Topical Ophthalmic Delivery
Stuart Williams
Favorite
Wirth, Steffen
University of Hamburg
(
M0930-06-35
)
Dust Emissions of Surrogate Substances Resulting from Diffusive and Convective Transport for Containment Investigations with a Newly Developed Two-Chamber Setup
Steffen Wirth
Favorite
Won, Jong-Hee
ChungNam National University
(
M1330-07-40
)
Enteric Coating and Evaluation of Optimized Curcumin-Loaded Nanostructured Lipid Carriers
Jong-Hee Won
Favorite
Wood, Caitlin
Merck & Co., Inc.
(
T1230-07-37
)
Using Enzymes to Accelerate PS80 Degradation and Elucidate Mechanistic Impacts of PS80 Degradation on Biologics Drug Product Quality
Caitlin Wood
Favorite
Woodring, Ryan
University of North Carolina at Chapel Hill
(
T1430-03-13
)
A Novel Therapeutic Platform for Improved Glioblastoma Treatment
Ryan Woodring
Favorite
Worrall, Christopher
University of Manchester, UK
(
T1530-01-03
)
Feeling the Pressure: Polymorphism, Particle Size and Morphology Control Through Nanoparticle Crystallization Using Controlled Expansion of Supercritical Solutions
Christopher Worrall
Favorite
Wu, Di
Merck & Co
(
M1330-02-10
)
Physiological Based Biopharmaceutics Modeling (PBBM) for pH-dependent DDI Risk Identification and Formulation Selection for a Weak Base Compound
Di Wu
Favorite
Wu, Fang
US Food and Drug Administration
(
M1130-11-64
)
Assessing the Impact of Excipient and Food Intake on Bioequivalence Using PBPK and Virtual Bioequivalence Trial: A Case Example with Acyclovir Immediate Release Tablets
Fang Wu
Favorite
Wu, Kai-Wei
US Food and Drug Administration
(
M1530-04-24
)
A Brief Review of FDA-Approved New Drug Applications Labeled with Sprinkle Administration
Kai-Wei Wu
Favorite
(
W1130-12-72
)
In Vitro Evaluation of an Extended Released Methylphenidate Hydrochloride Product Sprinkled on Food Vehicles
Kai-Wei Wu
Favorite
Wu, Shibo
University College London
(
M1430-04-20
)
Development of Novel Topical Formulations of 5-fluorouracil
Shibo Wu
Favorite
Back to Top
